Washington, D.C. 20549

                                     FORM 8-K

                                  CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 15, 2002

                           BioMarin Pharmaceutical Inc.
               (Exact name of registrant as specified in its charter)

                Delaware                000-26727                 68-0397820
(State or other jurisdiction of        (Commission              (IRS Employer
 incorporation or organization)        File Number)          Identification No.)

371 Bel Marin Keys Boulevard, Suite 210, Novato, California              94949
(Address of principal executive offices)                              (Zip Code)

Registrant's telephone number, including area code:          (415) 884-6700

                                 Not Applicable
             (Former name or former address, if changed since last report)

Item 5.  Other Events.

     On July 15, 2002, BioMarin Pharmaceutical Inc. (the "Registrant") announced
the  appointment of a new Chief  Financial  Officer and three new members of the
Registrant's  board of directors.  The Registrant's press release issued on July
15, 2002 is attached hereto as Exhibit 99.1.

Item 7.           Financial Statements, Pro Forma Financial Statements and

         (a)      Financial Statements of Business Acquired.

                  Not Applicable.

         (b)      Pro Forma Financial Information.

                  Not Applicable.

         (c)      Exhibits.

                  Exhibit 99.1 Press Release of the Registrant dated July 15,


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        BioMarin Pharmaceutical Inc.,
                                        a Delaware corporation

Date: July 15, 2002                     By: /s/ Fredric D. Price
                                            Fredric D. Price
                                            Chairman and Chief Executive Officer

                                EXHIBIT INDEX

Exhibit No.                Description
-----------                -----------

Exhibit 99.1               Press Release of the Registrant dated July 15, 2002.